Median Sydney scores (0–3) for the antrum and corpus biopsy specimens at baseline (T0) and at 12 months' follow-up (T12) for patients who became H pylori negative as a result of treatment
| T0 | T12 | p Value3-150 | |
|---|---|---|---|
| Antrum | |||
| Chronic inflammation | 2 | 1 | <0.0001 |
| Active inflammation | 1 | 0 | <0.0001 |
| Atrophy | 3 | 2 | 0.0009 |
| Intestinal metaplasia | 0 | 0 | — |
| H pyloridensity | 3 | 0 | <0.0001 |
| Corpus | |||
| Chronic inflammation | 2 | 1 | 0.0001 |
| Active inflammation | 1 | 0 | <0.0001 |
| Atrophy | 1 | 1 | 0.12 |
| Intestinal metaplasia | 0 | 0 | — |
| H pyloridensity | 2 | 0 | <0.0001 |
↵3-150 Wilcoxon two sample test.